Article
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats
16 Nov 2010
Abstract excerpt
BACKGROUND: microsatellite instability (MSI) is commonly screened using a panel of two mononucleotide and three dinucleotide repeats as recommended by a consensus meeting on MSI tumours held at the National Cancer Institute (Bethesda, MD, USA). According to these recommendations, tumours are classified as MSI-H when at least two of the five microsatellite markers show instability, MSI-L when only one marker shows...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
